Nick Dyson, PhD, has been appointed scientific director of the Mass General Cancer Center. Since joining the center 20 years ago, Dyson has established himself as an international leader in the study of cell cycle regulation. His findings have the potential to guide the design of novel, genetically focused therapies for many cancers.
“Dr. Dyson brings to this position an outstanding record of scientific accomplishments, a strong commitment to the success of our basic and translational cancer research programs, and an exceptional dedication to supporting and mentoring our junior faculty and trainees,” says Daniel Haber, MD, PhD, director of the Cancer Center.
In his new role, Dyson will oversee laboratory investigators within the Center for Cancer Research and help shape the scientific vision of the Cancer Center. He succeeds Jeffrey Settleman, PhD, who left Mass General last year to lead oncology discovery at Genentech.
Read more articles from the 02/03/12 Hotline issue.